Osteopontin (OPN) is a secreted phosphoprotein that has been implicated in the development and progression of several solid tumors. In the previous project, we have identified OPN as a secreted marker for tumor hypoxia and a powerful prognostic marker for head and neck (H&N) cancers. It is therefore a natural progression for this project to focus on the role of OPN on tumor progression in H&N cancers. The major goal of this project is to systematically investigate the effect of OPN and its individual domains on tumor invasion and metastasis in H&N cancers and to explore the possibility of targeting OPN using OPN blocking antibodies as a novel anticancer therapy. Specifically, we will generate stable cell lines expressing full-length OPN, its individual domains or its mutant constructs under a tetracycline-regulatable promoter in an H&N cancer cell line that is known to have minimal basal OPN expression. We will determine the impact of OPN and its domains on cell invasion and metastasis under normoxia and hypoxia in vitro and in vivo. We will use molecular tools to explore the mechanisms by which OPN enhances tumor invasion in H&N cancers. At the same time, we will evaluate the impact of blocking the expression OPN and its domains using domain- specific antibodies (abs) on tumor invasion, growth and metastasis in nude-mouse xenografts and to explore the use of OPN blocking abs for novel therapy. Dinitrobenzamide mustards (DNBMs) constitute a new and highly potent class of hypoxic cytotoxins that will be studied in detail in Project 2. Since we have found that OPN significantly enhances H&N cancer cell invasion and metastasis under hypoxia, we hypothesize that targeting both OPN and hypoxia may be better than targeting individual component alone. Therefore, the last specific aim of the project will evaluate the efficacy of combining OPN abs with PR-104 + radiation on tumor growth and metastasis in comparison to each treatment alone. In summary, the proposed aims are intended to answer the fundamental questions about the mechanisms by which OPN enhances the malignant tumor phenotype in H&N cancers and to identify the optimal approach to target this protein for clinical use.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA067166-12
Application #
7558954
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
12
Fiscal Year
2008
Total Cost
$273,929
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Saiki, Julie P; Cao, Hongbin; Van Wassenhove, Lauren D et al. (2018) Aldehyde dehydrogenase 3A1 activation prevents radiation-induced xerostomia by protecting salivary stem cells from toxic aldehydes. Proc Natl Acad Sci U S A 115:6279-6284
Olcina, Monica M; Kim, Ryan K; Melemenidis, Stavros et al. (2018) The tumour microenvironment links complement system dysregulation and hypoxic signalling?. Br J Radiol :20180069
Vilalta, Marta; Brune, Jourdan; Rafat, Marjan et al. (2018) The role of granulocyte macrophage colony stimulating factor (GM-CSF) in radiation-induced tumor cell migration. Clin Exp Metastasis 35:247-254
Tandon, Neha; Thakkar, Kaushik N; LaGory, Edward L et al. (2018) Generation of Stable Expression Mammalian Cell Lines Using Lentivirus. Bio Protoc 8:
Yang, Zhifen; Zhang, Jing; Jiang, Dadi et al. (2018) A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1?-XBP1 Activation. Mol Cancer Res 16:745-753
Benej, Martin; Hong, Xiangqian; Vibhute, Sandip et al. (2018) Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism. Proc Natl Acad Sci U S A 115:10756-10761
Rafat, Marjan; Aguilera, Todd A; Vilalta, Marta et al. (2018) Macrophages Promote Circulating Tumor Cell-Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients. Cancer Res 78:4241-4252
Castellini, Laura; Moon, Eui Jung; Razorenova, Olga V et al. (2017) KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage. Nucleic Acids Res 45:3674-3692
VandeKopple, Matthew J; Wu, Jinghai; Baer, Lisa A et al. (2017) Stress-responsive HILPDA is necessary for thermoregulation during fasting. J Endocrinol 235:27-38
Peinado, H├ęctor; Zhang, Haiying; Matei, Irina R et al. (2017) Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer 17:302-317

Showing the most recent 10 out of 203 publications